Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arcturus Therapeutics Holdings Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ARCT
Nasdaq
2830
arcturusrx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
- Aug 31st, 2026 2:01 pm
Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
- Aug 27th, 2026 7:55 am
Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players
- Aug 21st, 2026 12:54 pm
Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse?
- Aug 20th, 2026 2:07 pm
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline
- Aug 11th, 2026 7:04 pm
Arcturus Therapeutics Q2 Earnings Call Highlights
- Aug 6th, 2026 4:04 pm
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates
- Aug 6th, 2026 3:20 pm
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress
- Aug 6th, 2026 2:01 pm
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
- Jul 28th, 2026 2:01 pm
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
- Jul 20th, 2026 2:01 pm
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
- Jul 3rd, 2026 5:06 am
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
- Jul 2nd, 2026 5:00 am
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
- Jun 5th, 2026 3:02 am
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary
- May 8th, 2026 6:30 am
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
- May 7th, 2026 3:55 pm
Arcturus Therapeutics Q1 Earnings Call Highlights
- May 7th, 2026 3:39 pm
Scroll